Related Experiment Video

Updated: Dec 26, 2025

Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases
04:59

Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases

Published on: June 20, 2025

695

Top 10 candidate aortic disease trials

R L Dalman1, A Wanhainen2, K Mani2

  • 1From the, Division of Vascular Surgery, Department of Surgery, Stanford Medicine, Stanford, CA, USA.

Journal of Internal Medicine
|March 19, 2020
PubMed

Insights

This review highlights critical research gaps in aortic disease, emphasizing the need for updated natural history data and novel therapies for abdominal aortic aneurysm (AAA). Further studies on biomarkers, genetics, and metformin

Area of Science:

  • Cardiovascular Medicine
  • Vascular Surgery
  • Medical Research

Background:

  • Aortic diseases like aneurysm, dissection, and trauma are common and life-threatening.
  • Significant advancements have been made, yet substantial research opportunities remain.
  • Current treatments for abdominal aortic aneurysm (AAA) lack therapies for small aneurysms to prevent expansion and rupture.

Purpose of the Study:

  • To identify key areas for further study in aortic disease.
  • To prioritize essential aortic disease clinical trials.
  • To address limitations in current AAA management strategies.

Main Methods:

  • Literature review and analysis of current research trends.
  • Identification of knowledge gaps in aortic disease progression and treatment.
  • Selection of priority clinical trials for future investigation.

Main Results:

  • Need for updated AAA natural history data and endovascular repair roles.
  • Importance of defining biomarkers, genetic risk factors, and gender's influence.
  • Metformin identified as a potential drug candidate to slow AAA growth, requiring RCTs.

Conclusions:

  • Further research is crucial to refine understanding and treatment of aortic pathologies.
  • Clinical trials are warranted to validate metformin's efficacy in slowing AAA growth.
  • The role of endovascular treatment for ascending aortic pathologies and uncomplicated type B aortic dissection requires clarification.
Keywords:
aneurysmaortaclinical trialsdissectionendovascularmedical treatmentsurgery

More Related Videos

Author Spotlight: Development and Characterization of a Mouse Model for Abdominal Aortic Aneurysm05:07

Author Spotlight: Development and Characterization of a Mouse Model for Abdominal Aortic Aneurysm

Published on: August 2, 2024

1.5K
Murine Surgical Model of Topical Elastase Induced Descending Thoracic Aortic Aneurysm08:33

Murine Surgical Model of Topical Elastase Induced Descending Thoracic Aortic Aneurysm

Published on: August 24, 2019

8.0K

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
149
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
301
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.1K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
380
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
291